(Q39633120)

English

Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamate.

scientific article published on February 1988

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3280127

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3280127%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 September 2019

review article

1 reference

stated in

Europe PubMed Central

title

Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamate (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3280127

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3280127%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

S I Deutsch

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3280127

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3280127%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 September 2019

J M Morihisa

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3280127

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3280127%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 September 2019

publication date

1 February 1988

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3280127

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3280127%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 September 2019

published in

Clinical Neuropharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3280127

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3280127%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 September 2019

volume

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3280127

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3280127%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 September 2019

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3280127

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3280127%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 September 2019

page(s)

18-35

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3280127

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3280127%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 September 2019

Identifiers

DOI

10.1097/00002826-198802000-00002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3280127

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3280127%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 September 2019

PubMed publication ID

3280127

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3280127

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3280127%20AND%20SRC:MED&resulttype=core&format=json

(Q39633120)

Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamate.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)